Allergy Treatment
Publication Date
February 2024
USD 29.15 billion
USD 52.12 billion
USD 31.56 billion
Allergy Treatment Market by Type (Asthma, Eye Allergy, Food Allergy), Treatment Type (Anti-Allergy Drugs, Immunotherapy), Route of Administration, Distribution Channel - Global Forecast 2024-2030

[197 Pages Report] The Allergy Treatment Market size was estimated at USD 29.15 billion in 2023 and expected to reach USD 31.56 billion in 2024, at a CAGR 8.65% to reach USD 52.12 billion by 2030.

Allergy Treatment Market
To learn more about this report, request a free sample copy
Allergy treatment encompasses a range of medical practices aimed at alleviating or eliminating symptoms induced by allergic reactions. Treatment options range from preventive strategies and over-the-counter remedies to prescription medications and immunotherapy, catering to various allergy types such as food, seasonal, and pet allergies. The primary drivers include the prevalence of allergic disorders, greater awareness of treatment options, and advancements in allergy diagnostics. The rising pollution levels globally and changes in dietary habits have contributed to its adoption. Factors such as self-medication with over-the-counter drugs leading to underdiagnosis of allergies, a lack of awareness in developing regions, and the high cost of allergy treatments, including immunotherapy hinder the use. Additionally, stringent regulatory policies for approving new medications can impede progress. Challenges involve the need for personalized medicine approaches due to the variability in individual reactions, the paucity of trained healthcare professionals in allergology, and the need to manage the balance between efficacy and side effects of allergy medications. Opportunities include the development of novel therapeutic drugs and devices, exploring untapped markets in emerging economies, and the potential for technological advancements that improve diagnosis and patient adherence to treatment regimens.
Allergy Treatment Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Allergy Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Allergy Treatment Market, highlighting leading vendors and their innovative profiles. These include ALK-Abelló A/S, Alladapt Immunotherapeutics, Inc., Allergopharma GmbH & Co. KG, Allergy Therapeutics PLC, Bayer AG, Bristol-Myers Squibb Company, ClostraBio, Inc., Connote Healthcare, DBV Technologies, GentiBio, Inc., GlaxoSmithKline PLC, HollisterStier Allergy, IgGenix, Inc., Indoor Biotechnologies, Inc., Inimmune, Monark Biocare Private Limited, OptiNose US, Inc., Reacta Healthcare, Sanofi S.A., Stallergenes Greer International AG, Taiho Pharmaceutical Co., Ltd., Third Harmonic Bio, Trillium Health Care Products, Inc, and Upstream Bio, Inc..

Market Segmentation & Coverage

This research report categorizes the Allergy Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Asthma
    • Eye Allergy
    • Food Allergy
    • Rhinitis
    • Skin Allergy
  • Treatment Type
    • Anti-Allergy Drugs
    • Immunotherapy
  • Route of Administration
    • Nasal
    • Oral
    • Parenteral
  • Distribution Channel
    • Offline
      • Drug Stores
      • Retail Pharmacies
    • Online

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Allergy Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Allergy Treatment Market?
  4. What is the market share of the leading vendors in the Allergy Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Allergy Treatment Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Allergy Treatment Market, by Type
  7. Allergy Treatment Market, by Treatment Type
  8. Allergy Treatment Market, by Route of Administration
  9. Allergy Treatment Market, by Distribution Channel
  10. Americas Allergy Treatment Market
  11. Asia-Pacific Allergy Treatment Market
  12. Europe, Middle East & Africa Allergy Treatment Market
  13. Competitive Landscape
  14. Competitive Portfolio
Companies Mentioned
  • ALK-Abelló A/S
  • Alladapt Immunotherapeutics, Inc.
  • Allergopharma GmbH & Co. KG
  • Allergy Therapeutics PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • ClostraBio, Inc.
  • Connote Healthcare
  • DBV Technologies
  • GentiBio, Inc.
  • GlaxoSmithKline PLC
  • HollisterStier Allergy
  • IgGenix, Inc.
  • Indoor Biotechnologies, Inc.
  • Inimmune
  • Monark Biocare Private Limited
  • OptiNose US, Inc.
  • Reacta Healthcare
  • Sanofi S.A.
  • Stallergenes Greer International AG
  • Taiho Pharmaceutical Co., Ltd.
  • Third Harmonic Bio
  • Trillium Health Care Products, Inc
  • Upstream Bio, Inc.
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Allergy Treatment Market
The Global Allergy Treatment Market size was estimated at USD 29.15 billion in 2023 and expected to reach USD 31.56 billion in 2024.
The Global Allergy Treatment Market to grow USD 52.12 billion by 2030, at a CAGR of 8.65%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.